David Lewis has 25 years of healthcare experience and is currently the Managing Partner of Gilmartin Capital, a growth equity investment firm focused on the Medical Device, Life Science Tool and Digital Health sectors. Prior to founding Gilmartin Capital, David was a Managing Director at Morgan Stanley and Head of Morgan Stanley’s medical technology equity research practice from 2006-2021. During that period, he was a top decile analyst within Morgan Stanley’s Global Performance System, Institutional Investor (II) Medical Supplies & Devices Top 3 Analyst 2012-2017 and top II vote recipient 2018-2020. Before joining Morgan Stanley, David was a Partner and top ranked medical technology analyst at Thomas Weisel Partners and a founding member of the healthcare practice. David received a BA in healthcare policy with honors from the University of Pennsylvania. David Lives outside San Francisco with his wife Lynn, daughter Olivia, son Jack, and dog Tucker. He is a struggling guitar player and recovering A cappella singer and loves the mountains in any season.